Loughborough, United Kingdom

Mark Furber

USPTO Granted Patents = 21 

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 132(Granted Patents)


Location History:

  • Derby, GB (1993 - 1994)
  • Kegworth, GB (1995)
  • Leics, GB (2000 - 2002)
  • Keworth, GB (2002)
  • Loughborough, GB (2000 - 2011)

Company Filing History:


Years Active: 1993-2011

Loading Chart...
21 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I would love to help you with that. Mark Furber is a prolific inventor based in Loughborough, GB, with an impressive portfolio of 21 patents. His latest patents include innovative compounds such as Piperidines as chemokine modulators (CCR), which are used as modulators of chemokine (CCR3) activity for treating conditions like asthma.

In his distinguished career, Mark Furber has worked with renowned companies like AstraZeneca AB and AstraZeneca UK Limited. These companies are key players in the pharmaceutical industry, known for their groundbreaking research and development in the healthcare sector.

Throughout his career, Mark has collaborated with esteemed professionals such as David K. Donald and Martin E. Cooper. These collaborations have been vital in the development and commercialization of his patented inventions, showcasing his ability to work effectively in team settings to drive innovation forward.

In conclusion, Mark Furber stands out as a leading inventor in the pharmaceutical field, with a strong track record of patents that demonstrate his commitment to advancing healthcare through innovative solutions. His collaborations with top experts in the industry further solidify his reputation as a respected figure in the world of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…